Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 1.4T | 1.2T | 1.1T | 984.0B |
Cost of revenue | 1.1T | 940.2B | 884.1B | 791.1B |
Gross profit | 284.9B | 251.2B | 201.2B | 192.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 217.4B | 166.1B | 155.5B | 156.4B |
Other operating expenses | 3.4B | 4.8B | 9.5B | 219M |
Operating income | 89.1B | 91.7B | 47.5B | 52.2B |
Non operating interest income | ||||
Income | 21.8B | 2.8B | 11.3B | 28.7B |
Expense | 5.2B | 19.6B | 2.2B | 4.9B |
Other income expense | — | — | — | — |
Pretax income | 107.6B | 73.9B | 58.0B | 75.7B |
Tax provision | 20.2B | 22.3B | 12.0B | 17.1B |
Net income | 87.4B | 51.6B | 46.0B | 58.6B |
Basic EPS | — | 13.7 | 11.5 | 15.8 |
Diluted EPS | — | 13.7 | 11.5 | 15.8 |
Basic average shares | — | 3.4B | 3.4B | 3.4B |
Diluted average shares | — | 3.4B | 3.4B | 3.4B |
EBITDA | 163.3B | 130.7B | 95.1B | 113.9B |
Net income from continuing op. | 107.6B | 73.9B | 58.0B | 75.7B |
Minority interests | -3.4B | -5.5B | -7.2B | -5.4B |
Preferred stock dividends | 0 | 0 | 0 | 0 |